Park Ha Biological Technology (BYAH) Receivables (2023 - 2025)

Park Ha Biological Technology's Receivables history runs 3 years deep, the most recent figure standing at $1.4 million for Q4 2025.

• In Q4 2025, Receivables rose 16.4% year-over-year to $1.4 million; the TTM figure through Oct 2025 stood at $1.4 million (up 16.4% YoY), while the FY2025 annual figure was $1.4 million, up 16.4% from the prior year.
• Receivables was $1.4 million for Q4 2025 at Park Ha Biological Technology, up from $1.2 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $1.4 million in Q4 2025 to a low of $368012.0 in Q4 2023.
• Historically, Receivables has averaged $974014.0 across 3 years, with a median of $1.2 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Receivables jumped 220.7% in 2024, then advanced 16.4% in 2025.
• A 3-year view of Receivables shows it stood at $368012.0 in 2023, then surged by 220.7% to $1.2 million in 2024, then climbed by 16.4% to $1.4 million in 2025.
• The last three Receivables figures came in at $1.4 million (Q4 2025), $1.2 million (Q4 2024), and $368012.0 (Q4 2023), per Business Quant data.